Literature DB >> 11055582

Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission.

M Kubera1, G Kenis, E Bosmans, A Zieba, D Dudek, G Nowak, M Maes.   

Abstract

There is now some evidence that major depression is accompanied by an immune response with an increased production of pro-inflammatory cytokines. The aim of the present study was to examine serum level of cytokines: interleukin-6 (IL-6), which is considered pro-inflammatory one and anti-inflammatory cytokines: interleukin 10 (IL-10), and interleukin-1 receptor antagonist (IL-1Ra) in acute clinical state of depression and after 6-week antidepressant treatment. Serum IL-6, IL-10, IL-1Ra levels were higher in the subjects with major depression than in normal controls although these results were not statistically significant. The mean score according to the Hamilton Depression Rating Scale (HDRS) in the patients significantly decreased during the 6 weeks of the study, demonstrating an overall improvement. Successful antidepressant treatment had no significant effect on serum level of this cytokines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11055582

Source DB:  PubMed          Journal:  Pol J Pharmacol        ISSN: 1230-6002


  29 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

2.  What can post-mortem studies tell us about the pathoetiology of suicide?

Authors:  Ghanshyam N Pandey; Yogesh Dwivedi
Journal:  Future Neurol       Date:  2010-09

Review 3.  The inflammation hypothesis in geriatric depression.

Authors:  George S Alexopoulos; Sarah Shizuko Morimoto
Journal:  Int J Geriatr Psychiatry       Date:  2011-03-02       Impact factor: 3.485

4.  Immune system inflammation in cocaine dependent individuals: implications for medications development.

Authors:  Helen C Fox; Carrol D'Sa; Anne Kimmerling; Kristen M Siedlarz; Keri L Tuit; Raymond Stowe; Rajita Sinha
Journal:  Hum Psychopharmacol       Date:  2012-03       Impact factor: 1.672

5.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

6.  Reciprocal moderation by Toxoplasma gondii seropositivity and blood phenylalanine - tyrosine ratio of their associations with trait aggression.

Authors:  Ashwin Jacob Mathai; Christopher A Lowry; Thomas B Cook; Lisa A Brenner; Lena Brundin; Maureen W Groer; Xiaoqing Peng; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Dietmar Fuchs; Dan Rujescu; Teodor T Postolache
Journal:  Pteridines       Date:  2016-10-21       Impact factor: 0.581

7.  The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.

Authors:  Jonas Hannestad; Nicole DellaGioia; Michael Bloch
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

8.  Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections.

Authors:  Enrico Domenici; David R Willé; Federica Tozzi; Inga Prokopenko; Sam Miller; Astrid McKeown; Claire Brittain; Dan Rujescu; Ina Giegling; Christoph W Turck; Florian Holsboer; Edward T Bullmore; Lefkos Middleton; Emilio Merlo-Pich; Robert C Alexander; Pierandrea Muglia
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

Review 9.  A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.

Authors:  Rushaniya A Khairova; Rodrigo Machado-Vieira; Jing Du; Husseini K Manji
Journal:  Int J Neuropsychopharmacol       Date:  2009-02-19       Impact factor: 5.176

10.  Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder.

Authors:  Tanel Traks; Kati Koido; Triin Eller; Eduard Maron; Külli Kingo; Veiko Vasar; Eero Vasar; Sulev Kõks
Journal:  BMC Med Genet       Date:  2008-12-16       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.